| 2014年12月8日 |
Ito, M., Hayashi, K., Adachi, E., Minamisawa, T., Homma, S., Koido, S., Shiba, K. Combinatorial contextualization of peptidic epitopes for enhanced cellular immunity.
PLoS One, 9, e110425 (2014) |
| 2014年12月5日 |
Isoyama, S., Kajiwara, G., Tamaki, N., Okamura, M., Yoshimi, H., Nakamura, N., Kawamura, K., Nishimura, Y., Namatame, N., Yamori, T., Dan, S. Basal expression of IGF-1 receptor determines intrinsic resistance of cancer cells to a PI3K inhibitor ZSTK474.
Cancer Sci, 106, 171-178 (2015) |
| 2014年11月21日 |
Uehara, Y., Inoue, M., Fukuda, K., Yamakoshi, H., Hosoi, Y., Kanda, H., Oshima, M., Iwabuchi, Y., Shibata, H. Inhibition of β-catenin and STAT3 with a curcumin analog suppresses gastric carcinogenesis in vivo.
Gastric cancer, in press (2014) |
| 2014年11月21日 |
Sekiguchi, K., Ogawa, Y., Sanuki, N., Arahira, S., Ogo, E., Yoshimura, M., Yamauchi, C., Oguchi, M., Ohsumi, S., Mukai, H. The Japanese Breast Cancer Society clinical practice guideline for radiotherapy of breast cancer.
Breast Cancer, in press (2014) |
| 2014年11月21日 |
Honma, N., Horii, R., Iwase, T., Saji, S., Younes, M., Ito, Y., Akiyama, F. Proportion of estrogen or progesterone receptor expressing cells in breast cancers and response to endocrine therapy.
Breast, in press (2014) |
| 2014年11月21日 |
Yamaguchi, J., Nagayama, S., Chino, A., Sakata, A., Yamamoto, N., Sato, Y., Ashihara, Y., Kita, M., Nomura, S., Ishikawa, Y., Igarashi, M., Ueno, M., Arai, M. Identification of coding exon 3 duplication in the BMPR1A gene in a patient with juvenile polyposis syndrome.
Jpn J Clin Oncol, in press (2014) |
| 2014年11月21日 |
Horii, R., Matsuura, M., Dan, S., Ushijima, M., Uehiro, N., Ogiya, A., Honma, N., Ito, Y., Iwase, T., Yamori, T., Akiyama, F. Extensive analysis of signaling pathway molecules in breast cancer: association with clinicoapthological characteristics.
Int J Clin Oncol, in press (2014) |
| 2014年11月21日 |
Nakagawa, T., Horii, R., Ito, Y., Iwase, T., Akiyama, F. Development of an easy method to test for HER2 in breast cancer using dual-color in situ hybridization.
Breast Cancer, in press (2014) |
| 2014年11月21日 |
Katayama, R., Friboulet, L., Koike, S., Lockerman, E.L., Khan, T.M., Gainor, J.F., Iafrate, A.J., Takeuchi, K., Taiji, M., Okuno, Y., Fujita, N., Engelman, J.A., Shaw, A.T. Two novel ALK mutations mediate acquired resistance to the next-generation AKL inhibitor alectinib.
Clin Cancer Res, in press (2014) |
| 2014年11月21日 |
Kim, S.J., Masuda, N., Tsukamoto, F., Inaji, H., Akiyama, F., Sonoo, H., Kurebayashi, J., Yoshidome, K., Tsujimoto, M., Takei, H., Masuda, S., Nakamura, S., Noguchi, S. The cell cycle profiling-risk score based on CDK1 and 2 predicts early recurrence in node-negative, hormone receptor-positive breast cancer treated with endocrine therapy.
Cancer Lett, 355, 217-223 (2014) |
